Alva Emily Peterson has filed 33 insider transactions across 2 companies since May 2023.
Most recent transaction: a option exercise of 40258 shares of Amneal Pharmaceuticals, Inc. ($AMRX) on May 05, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | M | Class A Common Stock | 40258 | $0.00 | 211,029.0000 | 308,978,000 | 23.57% | 0.01% |
| May 6, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | A | Restricted Stock Units | 34819 | $0.00 | 34,819.0000 | 308,978,000 | 9999.99% | 0.01% |
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | M | Restricted Stock Units | 40258 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.01% |
| March 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | S | Class A Common Stock | 80000 | $8.90 | 170,771.0000 | 308,978,000 | 31.90% | 0.03% |
| June 29, 2024 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | M | Ordinary Shares | 6104 | $0.00 | 28,767.0000 | 169,730,000 | 26.93% | 0.00% |
| June 29, 2024 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | M | Restricted Stock Unit Award | 6104 | $0.00 | 0.0000 | 169,730,000 | 100.00% | 0.00% |
| June 29, 2024 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | F | Ordinary Shares | 1465 | $24.10 | 27,302.0000 | 169,730,000 | 5.09% | 0.00% |
| June 9, 2024 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | M | Restricted Stock Unit Award | 3871 | $0.00 | 0.0000 | 169,730,000 | 100.00% | 0.00% |
| June 9, 2024 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | M | Ordinary Shares | 3871 | $0.00 | 23,593.0000 | 169,730,000 | 19.63% | 0.00% |
| June 9, 2024 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | F | Ordinary Shares | 930 | $23.91 | 22,663.0000 | 169,730,000 | 3.94% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | J | Non Qualified Stock Option (Right to Buy) | 313 | $24.24 | 15,990.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | J | Non Qualified Stock Option (Right to Buy) | 22 | $24.22 | 1,137.0000 | 163,742,000 | 1.97% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | J | Non Qualified Stock Option (Right to Buy) | 455 | $24.22 | 23,214.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | J | Restricted Stock Unit Award | 75 | $0.00 | 3,871.0000 | 163,742,000 | 1.98% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | J | Non Qualified Stock Option (Right to Buy) | 231 | $30.86 | 11,785.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | J | Non Qualified Stock Option (Right to Buy) | 254 | $30.72 | 12,986.0000 | 163,742,000 | 1.99% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | J | Restricted Stock Unit Award | 119 | $0.00 | 6,104.0000 | 163,742,000 | 1.99% | 0.00% |
| May 31, 2024 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | A | Restricted Stock Unit Award | 8013 | $0.00 | 8,013.0000 | 169,730,000 | 9999.99% | 0.00% |
| May 31, 2024 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | A | Non Qualified Stock Option (Right to Buy) | 17492 | $0.00 | 17,492.0000 | 169,730,000 | 9999.99% | 0.01% |
| May 10, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | M | Class A Common Stock | 76453 | $0.00 | 250,771.0000 | 176,136,000 | 43.86% | 0.04% |
| May 10, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | M | Restricted Stock Units | 76453 | $0.00 | 0.0000 | 176,136,000 | 100.00% | 0.04% |
| May 2, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | A | Restricted Stock Units | 40258 | $0.00 | 40,258.0000 | 176,136,000 | 9999.99% | 0.02% |
| July 7, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | M | Restricted Stock Unit Award | 5957 | $0.00 | 0.0000 | 163,742,000 | 100.00% | 0.00% |
| July 7, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | F | Ordinary Shares | 1430 | $29.88 | 19,722.0000 | 163,742,000 | 6.76% | 0.00% |
| July 7, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | M | Ordinary Shares | 5957 | $0.00 | 21,152.0000 | 163,742,000 | 39.20% | 0.00% |
| June 29, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | A | Restricted Stock Unit Award | 5985 | $0.00 | 5,985.0000 | 163,742,000 | 9999.99% | 0.00% |
| June 29, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | A | Non Qualified Stock Option (Right to Buy) | 12732 | $0.00 | 12,732.0000 | 163,742,000 | 9999.99% | 0.01% |
| June 9, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | M | Restricted Stock Unit Award | 3795 | $0.00 | 3,796.0000 | 163,742,000 | 49.99% | 0.00% |
| June 9, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | F | Ordinary Shares | 911 | $31.13 | 15,195.0000 | 163,742,000 | 5.66% | 0.00% |
| June 9, 2023 | Alkermes plc. | $ALKS | Alva Emily Peterson | Director | M | Ordinary Shares | 3795 | $0.00 | 16,106.0000 | 163,742,000 | 30.83% | 0.00% |
| May 9, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | A | Restricted Stock Units | 76453 | $0.00 | 76,453.0000 | 150,944,000 | 9999.99% | 0.05% |
| May 10, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | M | Class A Common Stock | 80128 | $0.00 | 174,318.0000 | 150,944,000 | 85.07% | 0.05% |
| May 10, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Alva Emily Peterson | Director | M | Restricted Stock Units | 80128 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 0.05% |